Journal of Antimicrobial Chemotherapy (2000) 45, 591-598
© 2000 The British Society for Antimicrobial Chemotherapy
Use of digoxigenin-labelled ampicillin in the identification of penicillin-binding proteins in Helicobacter pylori
a School of Microbiology and Immunology, University of New South Wales, Sydney 2052, NSW; b Department of Biological Sciences, Faculty of Informatics, Science and Technology, University of Western Sydney, Macarthur, PO Box 555, Campbelltown 2560, NSW; c School of Biochemistry and Molecular Genetics, University of New South Wales, Sydney 2052, NSW, Australia
Amoxycillin is used in current therapeutic regimens to treat the infection caused by the human gastric pathogen, Helicobacter pylori. The penicillin-binding proteins (PBPs) are the primary targets for the ß-lactam antibiotics, such as amoxycillin, and are involved in the terminal stages of peptidoglycan synthesis. They also play active roles in the determination and maintenance of cellular morphology. It was believed that an organism with a complex morphology, such as H. pylori, would have more than the three PBPs previously suggested. Using digoxigenin-labelled ampicillin (DIG-ampicillin), we report the identification of eight PBPs in H. pylori with masses of 72, 62, 54, 50, 44, 33.5, 30.5 and 28 kDa. A smaller (21 kDa) ninth band was also detected, which may represent another PBP. However, the relatively small size of this apparent PBP raises questions as to whether this is a true PBP. In an attempt to identify the PBPs to which amoxycillin preferentially binds, amoxycillin was used in competition assays with DIG-ampicillin. It appeared that amoxycillin inhibited the binding of DIG-ampicillin to only the 72 kDa PBP. The experimental data were also compared with the seven putative PBPs identified in the two published H. pylori genomes, most of which correlate with the experimental data. To investigate further the properties of these PBPs, the seven putative PBP genes identified in the H. pylori genomes were examined. The derived amino acid sequences of the putative PBPs were examined for the three characteristic motifs found in all conventional PBPs, SXXK, SXN and KTG. We were able to determine that all of the putative PBPs had at least one of these motifs, but none possessed all three motifs with the characteristics of conventional PBPs. These findings suggest that the PBPs of H. pylori are unique.
* Corresponding author. Tel: +61-2-4620-3242; Fax: +61-2-4620-3793; E-mail: s.hazell{at}uws.edu.au
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E.-M. A. Co and N. L. Schiller Resistance Mechanisms in an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4174 - 4176. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Dassanayake, G. Sarath, and G. E. Duhamel Penicillin-Binding Proteins in the Pathogenic Intestinal Spirochete Brachyspira pilosicoli Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1561 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Kwon, M. P. Dore, J. J. Kim, M. Kato, M. Lee, J. Y. Wu, and D. Y. Graham High-Level {beta}-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2169 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Harris, J. E. Wilson, S. J. Danon, M. F. Dixon, K. Donegan, and S. L. Hazell Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model Microbiology, March 1, 2003; 149(3): 665 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okamoto, H. Yoshiyama, T. Nakazawa, I.-D. Park, M.-W. Chang, H. Yanai, K. Okita, and M. Shirai A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori J. Antimicrob. Chemother., December 1, 2002; 50(6): 849 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gerrits, D. Schuijffel, A. A. van Zwet, E. J. Kuipers, C. M. J. E. Vandenbroucke-Grauls, and J. G. Kusters Alterations in Penicillin-Binding Protein 1A Confer Resistance to {beta}-Lactam Antibiotics in Helicobacter pylori Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2229 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Cassell and J. Mekalanos Development of Antimicrobial Agents in the Era of New and Reemerging Infectious Diseases and Increasing Antibiotic Resistance JAMA, February 7, 2001; 285(5): 601 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. DeLoney and N. L. Schiller Characterization of an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori Antimicrob. Agents Chemother., December 1, 2000; 44(12): 3368 - 3373. [Abstract] [Full Text] |
||||



